Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|June 25, 2024
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual diseasePeter S Winter, Michelle L Ramseier, Andrew W Navia, et al.
The Journal of Investigative Dermatology|June 2, 2018
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg TypeXiaolong Alan Zhou, Abner Louissaint, Alexander Wenzel, et al.
Frontiers in Immunology|December 26, 2022
Protein re-surfacing of E. coli L-Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responsesAli Bootwala, Hyun Hwan An, Meghan Whitney Franklin, et al.
Blood Advances|May 14, 2021
Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countriesFabiola Valvert, Oscar Silva, Elizabeth Solórzano-Ortiz, et al.
British Journal of Haematology|December 30, 2021
The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cellsSarah Haebe, William Keay, Stefan Alig, et al.
Oncotarget|September 9, 2017
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinaseEllen L Weisberg, Alexandre Puissant, Richard Stone, et al.
Cell Reports|January 18, 2016
Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian CancerYoung Eun Choi, Khyati Meghani, Marie-Eve Brault, et al.
Blood|December 1, 2018
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomasRaphael Koch, Amanda L Christie, Jennifer L Crombie, et al.
Disaster Medicine and Public Health Preparedness|March 16, 2011
Allocation of scarce resources after a nuclear detonation: setting the contextAnn R Knebel, C Norman Coleman, Kenneth D Cliffer, et al.
Health Physics|January 1, 2015
Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterpriseC Norman Coleman, Julie M Sullivan, Judith L Bader, et al.
Pageof 17